Generate a tailored SOP for Dr. Alvin Kamili. Improve your application with a focused, well-structured draft.
Alvin Kamili is a Conjoint Senior Lecturer and a senior research officer in the ZERO Personalised Medicine Program at the Children’s Cancer Institute in Sydney, Australia. His research focuses on the establishment of preclinical models for neuroblastoma, a disease that often leads to relapse in patients suffering from drug-resistant conditions, which historically have low long-term survival rates of around 50%. His work aims to implement a personalised medicine approach to enhance patient survival by identifying molecular aberrations that drive cancer progression in individual patients. This includes screening ex vivo tumor cells against a library of anticancer drugs and developing improved pre-clinical testing models to advance therapeutic strategies against neuroblastoma.
Children’s Cancer Institute • Sydney, Australia
Leading research initiatives in the ZERO Personalised Medicine Program, focusing on neuroblastoma and developing personalised treatment strategies.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.